Query author contributions in Reactome
Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.
If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.
Details on Person Duchenne muscular dystrophy
| Class:Id | Disease:9717022 |
|---|---|
| _displayName | Duchenne muscular dystrophy |
| _timestamp | 2021-03-03 10:26:16 |
| created | [InstanceEdit:9717026] Stephan, Ralf, 2021-03-03 |
| definition | A muscular dystrophy that has_material_basis_in X-linked mutations in the DMD gene found on the X chromosome. It is characterized by rapidly progressing muscle weakness and muscle atrophy initially involving the lower extremities and eventually affecting the whole body. It affects males whereas females can be carriers. The symptoms start before the age of six and may appear at infancy. |
| identifier | 11723 |
| name | Duchenne muscular dystrophy |
| referenceDatabase | [ReferenceDatabase:1247631] DOID |
| synonym | Muscular dystrophy, Duchenne |
| (disease) | [ChemicalDrug:9717033] deflazacort [cytosol] |
| [Change default viewing format] | |
No pathways have been reviewed or authored by Duchenne muscular dystrophy (9717022)
